Benefits of lactoferrin, osteopontin and milk fat globule membranes for infants

Nutrients

Volumn 9, Issue 8, 2017, Pages

  Demmelmair, Hans ^a   Prell, Christine ^a   Timby, Niklas ^b   Lönnerdal, Bo ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioactive proteins; Human milk; Lactoferrin; Milk fat globule membrane; Osteopontin

Indexed keywords

ALPHA LACTALBUMIN; BETA CASEIN; BETA CASOMORPHINE; BUTYROPHILIN; HAPTOCORRIN; IMMUNOGLOBULIN A; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; KAPPA CASEIN; LACTADHERIN; LACTOFERRIN; LYSOZYME; MILK FAT GLOBULE MEMBRANE PROTEIN; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYLGLUCOSAMINE; OSTEOPONTIN; UNCLASSIFIED DRUG; GLYCOLIPID; GLYCOPROTEIN; MILK FAT GLOBULE;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BINDING AFFINITY; BIOLOGICAL ACTIVITY; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMAN; IMMUNOSTIMULATION; INFANT; INNATE IMMUNITY; MENTAL DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANALYSIS; BABY FOOD; CHEMISTRY; INFANT NUTRITION;

GLYCOLIPIDS; GLYCOPROTEINS; HUMANS; INFANT; INFANT FOOD; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; LACTOFERRIN; OSTEOPONTIN;

EID: 85026487538     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9080817     Document Type: Review

References (159)

1. Prell, C.; Koletzko, B. Breastfeeding and complementary feeding. Dtsch. Arztebl. Int. 2016, 113, 435-444.
2. Agostoni, C.; Braegger, C.; Decsi, T.; Kolacek, S.; Koletzko, B.; Michaelsen, K.F.; Mihatsch, W.; Moreno, L.A.; Puntis, J.; Shamir, R. et al. Breast-feeding: A commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2009, 49, 112-125.
3. Lönnerdal, B. Bioactive proteins in human milk: Mechanisms of action. J. Pediatr. 2010, 156, S26-S30.
4. Kramer, M.S.; Aboud, F.; Mironova, E.; Vanilovich, I.; Platt, R.W.; Matush, L.; Igumnov, S.; Fombonne, E.; Bogdanovich, N.; Ducruet, T. et al. Breastfeeding and child cognitive development: New evidence from a large randomized trial. Arch. Gen. Psychiatry 2008, 65, 578-584.
5. Chatterton, D.E.W.; Nguyen, D.N.; Bering, S.B.; Sangild, P.T. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int. J. Biochem. Cell. B 2013, 45, 1730-1747.
6. Garcia, C.; Duan, R.D.; Brevaut-Malaty, V.; Gire, C.; Millet, V.; Simeoni, U.; Bernard, M.; Armand, M. Bioactive compounds in human milk and intestinal health and maturity in preterm newborn: An overview. Cell. Mol. Biol. 2013,59, 108-131.
7. Hernell, O.; Timby, N.; Domellöf, M.; Lönnerdal, B. Clinical benefits of milk fat globule membranes for infants and children. J. Pediatr. 2016, 173, S60-S65.
8. Wada, Y.; Lönnerdal, B. Bioactive peptides released from in vitro digestion of human milk with or without pasteurization. Pediatr. Res. 2015, 77, 546-553.
9. Deglaire, A.; De Oliveira, S.C.; Jardin, J.; Briard-Bion, V.; Emily, M.; Menard, O.; Bourlieu, C.; Dupont, D. Impact of human milk pasteurization on the kinetics of peptide release during in vitro dynamic term newborn digestion. Electrophoresis 2016, 37, 1839-1850.
10. Dallas, D.C.; Smink, C.J.; Robinson, R.C.; Tian, T.; Guerrero, A.; Parker, E.A.; Smilowitz, J.T.; Hettinga, K.A.; Underwood, M.A.; Lebrilla, C.B. et al. Endogenous human milk peptide release is greater after preterm birth than term birth. J. Nutr. 2015, 145, 425-433.
11. Hansen, M.; Sandström, B.; Lönnerdal, B. The effect of casein phosphopeptides on zinc and calcium absorption from high phytate infant diets assessed in rat pups and Caco-2 cells. Pediatr. Res. 1996, 40, 547-552.
12. Wada, Y.; Lönnerdal, B. Bioactive peptides derived from human milk proteins-Mechanisms of action. J. Nutr. Biochem.2014, 25, 503-514.
13. Pellegrini, A.; Thomas, U.; Bramaz, N.; Hunziker, P.; von Fellenberg, R. Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule. Biochim. Biophys. Acta 1999, 1426, 439-448.
14. Strömqvist, M.; Falk, P.; Bergström, S.; Hansson, L.; Lönnerdal, B.; Normark, S.; Hernell, O. Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J. Pediatr. Gastroenterol. Nutr. 1995, 21, 288-296.
15. Lönnerdal, B.; Glazier, C. Calcium binding by alpha-lactalbumin in human milk and bovine milk. J. Nutr. 1985, 115, 1209-1216.
16. Ren, J.; Stuart, D.I.; Acharya, K.R. Alpha-lactalbumin possesses a distinct zinc binding site. J. Biol. Chem. 1993, 268, 19292-19298.
17. Bruck, W.M.; Kelleher, S.L.; Gibson, G.R.; Nielsen, K.E.; Chatterton, D.E.; Lönnerdal, B. rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 2003,37, 273-280.
18. Goldman, A.S. The immune system of human milk: Antimicrobial, antiinflammatory and immunomodulating properties. Pediatr. Infect. Dis. J. 1993, 12, 664-671.
19. Benkerroum, N. Antimicrobial activity of lysozyme with special relevance to milk. Afr. J. Biotechnol. 2008, 7, 4856-4867.
20. Akinbi, H.; Meinzen-Derr, J.; Auer, C.; Ma, Y.; Pullum, D.; Kusano, R.; Reszka, K.J.; Zimmerly, K. Alterations in the host defense properties of human milk following prolonged storage or pasteurization. J. Pediatr. Gastroenterol. Nutr. 2010, 51, 347-352.
21. Rudloff, S.; Kunz, C. Protein and nonprotein nitrogen components in human milk, bovine milk, and infant formula: Quantitative and qualitative aspects in infant nutrition. J. Pediatr. Gastroenterol. Nutr. 1997, 24, 328-344.
22. Teschemacher, H.; Koch, G.; Brantl, V. Milk protein-derived opioid receptor ligands. Biopolymers 1997, 43, 99-117.
23. Kost, N.V.; Sokolov, O.Y.; Kurasova, O.B.; Dmitriev, A.D.; Tarakanova, J.N.; Gabaeva, M.V.; Zolotarev, Y.A.; Dadayan, A.K.; Grachev, S.A.; Korneeva, E.V. et al. Beta-casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides 2009, 30, 1854-1860.
24. Meisel, H.; Bernard, H.; Fairweather-Tait, S.; FitzGerald, R.J.; Hartmann, R.; Lane, C.N.; McDonagh, D.; Teucher, B.; Wal, J.M. Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects. Br. J. Nutr. 2003, 89, 351-359.
25. Chabance, B.; Marteau, P.; Rambaud, J.C.; Migliore-Samour, D.; Boynard, M.; Perrotin, P.; Guillet, R.; Jolles, P.; Fiat, A.M. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998, 80, 155-165.
26. Jackson, J.G.; Janszen, D.B.; Lönnerdal, B.; Lien, E.L.; Pramuk, K.P.; Kuhlman, C.F. A multinational study of alpha-lactalbumin concentrations in human milk. J. Nutr. Biochem. 2004, 15, 517-521.
27. Lönnerdal, B.; Lien, E.L. Nutritional and physiologic significance of alpha-lactalbumin in infants. Nutr. Rev. 2003, 61, 295-305.
28. Sandström, O.; Lönnerdal, B.; Graverholt, G.; Hernell, O. Effects of alpha-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. Am. J. Clin. Nutr. 2008, 87, 921-928.
29. Rai, D.; Adelman, A.S.; Zhuang, W.; Rai, G.P.; Boettcher, J.; Lönnerdal, B. Longitudinal changes in lactoferrin concentrations in human milk: A global systematic review. Crit. Rev. Food Sci. Nutr. 2014, 54, 1539-1547.
30. Lönnerdal, B. Nutritional roles of lactoferrin. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12, 293-297.
31. Gifford, J.L.; Hunter, H.N.; Vogel, H.J. Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 2005, 62, 2588-2598.
32. Liepke, C.; Adermann, K.; Raida, M.; Magert, H.J.; Forssmann, W.G.; Zucht, H.D. Human milk provides peptides highly stimulating the growth of bifidobacteria. Eur. J. Biochem. 2002, 269, 712-718.
33. Ochoa, T.J.; Pezo, A.; Cruz, K.; Chea-Woo, E.; Cleary, T.G. Clinical studies of lactoferrin in children. Biochem. Cell. Biol.2012, 90, 457-467.
34. Davidson, L.A.; Lönnerdal, B. Persistence of human-milk proteins in the breast-fed infant. Acta Paediatr. Scand. 1987,76, 733-740.
35. Greibe, E.; Lildballe, D.L.; Streym, S.; Vestergaard, P.; Rejnmark, L.; Mosekilde, L.; Nexo, E. Cobalamin and haptocorrin in human milk and cobalamin-related variables in mother and child: A 9-mo longitudinal study. Am. J. Clin. Nutr. 2013,98, 389-395.
36. Adkins, Y.; Lönnerdal, B. Potential host-defense role of a human milk vitamin B-12-binding protein, haptocorrin, in the gastrointestinal tract of breastfed infants, as assessed with porcine haptocorrin in vitro. Am. J. Clin. Nutr. 2003, 77, 1234-1240.
37. Adkins, Y.; Lönnerdal, B. Mechanisms of vitamin B(12) absorption in breast-fed infants. J. Pediatr. Gastroenterol. Nutr.2002, 35, 192-198.
38. Lönnerdal, B. Biochemistry and physiological function of human milk proteins. Am. J. Clin. Nutr. 1985, 42, 1299-1317.
39. Hamosh, M. Protective function of proteins and lipids in human milk. Biol. Neonate 1998, 74, 163-176.
40. Liu, B.; Newburg, D.S. Human milk glycoproteins protect infants against human pathogens. Breastfeed Med. 2013, 8, 354-362.
41. Lindquist, S.; Hernell, O. Lipid digestion and absorption in early life: An update. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13, 314-320.
42. Casper, C.; Carnielli, V.P.; Hascoet, J.M.; Lapillonne, A.; Maggio, L.; Timdahl, K.; Olsson, B.; Vagero, M.; Hernell, O. rhBSSL improves growth and LCPUFA absorption in preterm infants fed formula or pasteurized breast milk. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 61-69.
43. Ruvoen-Clouet, N.; Mas, E.; Marionneau, S.; Guillon, P.; Lombardo, D.; Le Pendu, J. Bile-salt-stimulated lipase and mucins from milk of ‘secretor’ mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem. J. 2006, 393, 627-634.
44. Hamosh, M. Enzymes in human milk. In Handbook of Milk Composition; Jensen, R., Ed.; Academic Press: San Diego, CA, USA, 1995; pp 247-388.
45. Schack, L.; Lange, A.; Kelsen, J.; Agnholt, J.; Christensen, B.; Petersen, T.E.; Sorensen, E.S. Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas. J. Dairy Sci. 2009, 92, 5378-5385.
46. Donovan, S.M.; Monaco, M.H.; Drnevich, J.; Kvistgaard, A.S.; Hernell, O.; Lönnerdal, B. Bovine osteopontin modifies the intestinal transcriptome of formula-fed infant rhesus monkeys to be more similar to those that were breastfed. J. Nutr. 2014, 144, 1910-1919.
47. Lönnerdal, B.; Kvistgaard, A.S.; Peerson, J.M.; Donovan, S.M.; Peng, Y.M. Growth, nutrition, and cytokine response of breast-fed infants and infants fed formula with fdded bovine osteopontin. J. Pediatr. Gastroenterol. Nutr. 2016, 62, 650-657.
48. Casper, C.; Hascoet, J.M.; Ertl, T.; Gadzinowski, J.S.; Carnielli, V.; Rigo, J.; Lapillonne, A.; Couce, M.L.; Vagero, M.; Palmgren, I. et al. Recombinant bile balt-stimulated lipase in preterm infant feeding: A randomized phase 3 study. PLoS ONE 2016, 11, e0156071.
49. 4+ T cells. Antimicrob. Agents Chemother. 2006, 50, 3367-3374.
50. Lönnerdal, B. Nutritional and physiologic significance of human milk proteins. Am. J. Clin. Nutr. 2003, 77, 1537s-1543s.
51. Lönnerdal, B.; Iyer, S. Lactoferrin: Molecular structure and biological function. Annu. Rev. Nutr. 1995, 15, 93-110.
52. Hughes, A.L.; Friedman, R. Evolutionary diversification of the vertebrate transferrin multi-gene family. Immunogenetics 2014, 66, 651-661.
53. Garcia-Montoya, I.A.; Cendon, T.S.; Arevalo-Gallegos, S.; Rascon-Cruz, Q. Lactoferrin a multiple bioactive protein: An overview. BBA-Gen. Subjects 2012, 1820, 226-236.
54. Baker, E.N.; Baker, H.M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 2009, 91, 3-10.
55. Spik, G.; Coddeville, B.; Mazurier, J.; Bourne, Y.; Cambillaut, C.; Montreuil, J. Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans. Adv. Exp. Med. Biol. 1994, 357, 21-32.
56. Barboza, M.; Pinzon, J.; Wickramasinghe, S.; Froehlich, J.W.; Moeller, I.; Smilowitz, J.T.; Ruhaak, L.R.; Huang, J.; Lönnerdal, B.; German, J.B. et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Mol. Cell. Proteomics 2012, 11.
57. Harmsen, H.J.; Wildeboer-Veloo, A.C.; Raangs, G.C.; Wagendorp, A.A.; Klijn, N.; Bindels, J.G.; Welling, G.W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000, 30, 61-67.
58. Lönnerdal, B. Effects of milk and milk components on calcium, magnesium, and trace element absorption during infancy. Physiol. Rev. 1997, 77, 643-669.
59. Fransson, G.B.; Lönnerdal, B. Iron in human milk. J. Pediatr. 1980, 96, 380-384.
60. Hirai, Y.; Kawakata, N.; Satoh, K.; Ikeda, Y.; Hisayasu, S.; Orimo, H.; Yoshino, Y. Concentrations of lactoferrin and iron in human milk at different stages of lactation. J. Nutr. Sci. Vitaminol. (Tokyo) 1990, 36, 531-544.
61. Bullen, J.J.; Rogers, H.J.; Leigh, L. Iron-binding proteins in milk and resistance to Escherichia-Coli infection in infants. Br. Med. J. 1972, 1, 69-75.
62. Arnold, R.R.; Brewer, M.; Gauthier, J.J. Bactericidal activity of human lactoferrin-Sensitivity of a variety of microorganisms. Infect. Immun. 1980, 28, 893-898.
63. Arnold, R.R.; Russell, J.E.; Champion, W.J.; Gauthier, J.J. Bactericidal activity of human lactoferrin-Influence of physical conditions and metabolic state of the target microorganism. Infect. Immun. 1981, 32, 655-660.
64. Brandenburg, K.; Jurgens, G.; Muller, M.; Fukuoka, S.; Koch, M.H.J. Biophysical characterization of lipopolysaccharide and lipid a inactivation by lactoferrin. Biol. Chem. 2001, 382, 1215-1225.
65. Ellison, R.T.; Giehl, T.J.; Laforce, F.M. Damage of the outer-membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 1988, 56, 2774-2781.
66. Ellison, R.T.; Giehl, T.J. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Investog. 1991, 88, 1080-1091.
67. Jiang, R.L.; Du, X.G.; Lönnerdal, B. Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 642-652.
68. Alexander, D.B.; Iigo, M.; Yamauchi, K.; Suzui, M.; Tsuda, H. Lactoferrin: An alternative view of its role in human biological fluids. Biochem. Cell. Biol. 2012, 90, 279-306.
69. Fransson, G.B.; Keen, C.L.; Lönnerdal, B. Supplementation of milk with iron bound to lactoferrin using weanling mice: L. Effects on hematology and tissue iron. J. Pediatr. Gastroenterol. Nutr. 1983, 2, 693-700.
70. Suzuki, Y.A.; Shin, K.; Lönnerdal, B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 2001, 40, 15771-15779.
71. Liao, Y.L.; Jiang, R.L.; Lönnerdal, B. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life. Biochem. Cell. Biol. 2012, 90, 476-484.
72. Jiang, R.L.; Lopez, V.; Kelleher, S.L.; Lönnerdal, B. Apo-and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells. J. Cell. Physiol. 2011, 226, 3022-3031.
73. Mendoza, M.C.; Er, E.E.; Blenis, J. The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends Biochem. Sci. 2011, 36, 320-328.
74. He, J.L.; Furmanski, P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature1995, 373, 721-724.
75. Jiang, R.L.; Lönnerdal, B. Transcriptomic profiling of intestinal epithelial cells in response to human, bovine and commercial bovine lactoferrins. Biometals 2014, 27, 831-841.
76. Suzuki, Y.A.; Lopez, V.; Lönnerdal, B. Mammalian lactoferrin receptors: Structure and function. Cell. Mol. Life Sci. 2005,62, 2560-2575.
77. Iigo, M.; Shimamura, M.; Matsuda, E.; Fujita, K.; Nomoto, H.; Satoh, J.; Kojima, S.; Alexander, D.B.; Moore, M.A.; Tsuda, H. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: A possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 2004, 25, 36-44.
78. Spadaro, M.; Caorsi, C.; Ceruti, P.; Varadhachary, A.; Forni, G.; Pericle, F.; Giovarelli, M. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. Faseb. J. 2008, 22, 2747-2757.
79. Wang, W.P. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 2000, 91, 1022-1027.
80. De la Rosa, G.; Yang, D.; Tewary, P.; Varadhachary, A.; Oppenheim, J.J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 2008, 180, 6868-6876.
81. Field, C.J. The immunological components of human milk and their effect of immune development in infants. J. Nutr.2005, 135, 1-4.
82. Yoshida, A.; Wei, Z.; Shinmura, Y.; Fukunaga, N. Separation of lactoferrin-a and -b from bovine colostrum. J. Dairy Sci.2000, 83, 2211-2215.
83. Lönnerdal, B.; Jiang, R.L.; Du, X.O. Bovine Lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. J. Pediatr. Gastroenterol. Nutr. 2011, 53, 606-614.
84. Cooper, C.A.; Maga, E.A.; Murray, J.D. Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: Past, present, and future. Transgenic Res. 2015, 24, 605-614.
85. Yemets, A.I.; Tanasienko, I.V.; Krasylenko, Y.A.; Blume, Y.B. Plant-based biopharming of recombinant human lactoferrin. Cell. Biol. Int. 2014, 38, 989-1002.
86. Vogel, H.J. Lactoferrin, a bird‘s eye view. Biochem. Cell. Biol. 2012, 90, 233-244.
87. Lönnerdal, B. Biological effects of novel bovine milk fractions. Nestle Nutr. Workshop Ser. Pediatr. Program 2011, 67, 41-54.
88. Baker, H.M.; Baker, E.N. Lactoferrin and iron: Structural and dynamic aspects of binding and release. Biometals 2004,17, 209-216.
89. King, J.C., Jr.; Cummings, G.E.; Guo, N.; Trivedi, L.; Readmond, B.X.; Keane, V.; Feigelman, S.; de Waard, R. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J. Pediatr. Gastroenterol. Nutr. 2007, 44, 245-251.
90. Zavaleta, N.; Figueroa, D.; Rivera, J.; Sanchez, J.; Alfaro, S.; Lönnerdal, B. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J. Pediatr. Gastroenterol. Nutr. 2007, 44, 258-264.
91. Chen, K.; Chai, L.; Li, H.; Zhang, Y.; Xie, H.M.; Shang, J.; Tian, W.; Yang, P.; Jiang, A.C. Effect of bovine lactoferrin from iron-fortified formulas on diarrhea and respiratory tract infections of weaned infants in a randomized controlled trial. Nutrition 2016, 32, 222-227.
92. Ke, C.; Lan, Z.; Hua, L.; Ying, Z.; Humina, X.; Jia, S.; Weizheng, T.; Ping, Y.; Lingying, C.; Meng, M. Iron metabolism in infants: Influence of bovine lactoferrin from iron-fortified formula. Nutrition 2015, 31, 304-309.
93. Manzoni, P.; Rinaldi, M.; Cattani, S.; Pugni, L.; Romeo, M.G.; Messner, H.; Stolfi, I.; Decembrino, L.; Laforgia, N.; Vagnarelli, F. et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA 2009, 302, 1421-1428.
94. Pammi, M.; Abrams, S.A. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2015, 2, CD007137.
95. Christensen, B.; Sorensen, E.S. Structure, function and nutritional potential of milk osteopontin. Int. Dairy J. 2016, 57, 1.
96. Reinholt, F.P.; Hultenby, K.; Oldberg, A.; Heinegard, D. Osteopontin—A possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 1990, 87, 4473-4475.
97. Jiang, R.; Lönnerdal, B. Biological roles of milk osteopontin. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 214-219.
98. Bellahcene, A.; Castronovo, V.; Ogbureke, K.U.; Fisher, L.W.; Fedarko, N.S. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): Multifunctional proteins in cancer. Nat. Rev. Cancer 2008, 8, 212-226.
99. Kahles, F.; Findeisen, H.M.; Bruemmer, D. Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol. Metab. 2014, 3, 384-393.
100. Gimba, E.R.; Tilli, T.M. Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways. Cancer Lett. 2013, 331, 11-17.
101. Ashkar, S.; Weber, G.F.; Panoutsakopoulou, V.; Sanchirico, M.E.; Jansson, M.; Zawaideh, S.; Rittling, S.R.; Denhardt, D.T.; Glimcher, M.J.; Cantor, H. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 2000, 287, 860-864.
102. 4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 2008, 181, 7480-7488.
103. Rittling, S.R.; Singh, R. Osteopontin in immune-mediated diseases. J. Dent. Res. 2015, 94, 1638-1645.
104. Waller, A.H.; Sanchez-Ross, M.; Kaluski, E.; Klapholz, M. Osteopontin in cardiovascular disease: A potential therapeutic target. Cardiol. Rev. 2010, 18, 125-131.
105. Selvaraju, R.; Bernasconi, L.; Losberger, C.; Graber, P.; Kadi, L.; Avellana-Adalid, V.; Picard-Riera, N.; Baron Van Evercooren, A.; Cirillo, R.; Kosco-Vilbois, M. et al. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol. Cell. Neurosci. 2004, 25, 707-721.
106. Nagatomo, T.; Ohga, S.; Takada, H.; Nomura, A.; Hikino, S.; Imura, M.; Ohshima, K.; Hara, T. Microarray analysis of human milk cells: Persistent high expression of osteopontin during the lactation period. Clin. Exp. Immunol. 2004, 138, 47-53.
107. Joung, K.E.; Christou, H.; Park, K.H.; Mantzoros, C.S. Cord blood levels of osteopontin as a phenotype marker of gestational age and neonatal morbidities. Obesity (Silver Spring) 2014, 22, 1317-1324.
108. Chatterton, D.R.J.T.; Heegaard, C.W.; Sorensen, E.S.; Petersen, T.E. In vitro digestion of novel milk protein ingredients for use in infant formulas: Research on biological functions. Trends Food Sci. Technol. 2004, 15, 373-383.
109. Da Silva, A.P.; Ellen, R.P.; Sorensen, E.S.; Goldberg, H.A.; Zohar, R.; Sodek, J. Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab. Investig. 2009, 89, 1169-1181.
110. Rittling, S.R.; Wejse, P.L.; Yagiz, K.; Warot, G.A.; Hui, T. Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels. Br. J. Cancer 2014, 110, 1269-1277.
111. Kvistgaard, A.S.; Matulka, R.A.; Dolan, L.C.; Ramanujam, K.S. Pre-clinical in vitro and in vivo safety evaluation of bovine whey derived osteopontin, Lacprodan(R) OPN-10. Food Chem. Toxicol. 2014, 73, 59-70.
112. Kainonen, E.; Rautava, S.; Isolauri, E. Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. Br. J. Nutr. 2013, 109, 1962-1970.
113. Dewettinck, K.; Rombaut, R.; Thienpont, N.; Le, T.T.; Messens, K.; Van Camp, J. Nutritional and technological aspects of milk fat globule membrane material. Int. Dairy J. 2008, 18, 436-457.
114. Heid, H.W.; Keenan, T.W. Intracellular origin and secretion of milk fat globules. Eur. J. Cell. Biol. 2005, 84, 245-258.
115. Liao, Y.; Alvarado, R.; Phinney, B.; Lönnerdal, B. Proteomic characterization of human milk fat globule membrane proteins during a 12 month lactation period. J. Proteome Res. 2011, 10, 3530-3541.
116. Mather, I.H. A review and proposed nomenclature for major proteins of the milk-fat globule membrane. J. Dairy Sci.2000, 83, 203-247.
117. Peterson, J.A.; Hamosh, M.; Scallan, C.D.; Ceriani, R.L.; Henderson, T.R.; Mehta, N.R.; Armand, M.; Hamosh, P. Milk fat globule glycoproteins in human milk and in gastric aspirates of mother’s milk-fed preterm infants. Pediatr. Res. 1998,44, 499-506.
118. Peterson, J.A.; Patton, S.; Hamosh, M. Glycoproteins of the human milk fat globule in the protection of the breast-fed infant against infections. Biol. Neonate. 1998, 74, 143-162.
119. Liu, B.; Yu, Z.; Chen, C.; Kling, D.E.; Newburg, D.S. Human milk mucin 1 and mucin 4 inhibit Salmonella enterica serovar Typhimurium invasion of human intestinal epithelial cells in vitro. J. Nutr. 2012, 142, 1504-1509.
120. Saeland, E.; de Jong, M.A.; Nabatov, A.A.; Kalay, H.; Geijtenbeek, T.B.; van Kooyk, Y. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol. Immunol. 2009, 46, 2309-2316.
121. Koning, N.; Kessen, S.F.; Van Der Voorn, J.P.; Appelmelk, B.J.; Jeurink, P.V.; Knippels, L.M.; Garssen, J.; Van Kooyk, Y. Human milk blocks DC-SIGN-pathogen interaction via MUC1. Front. Immunol. 2015, 6, 112.
122. Battelli, M.G.; Polito, L.; Bortolotti, M.; Bolognesi, A. Xanthine Oxidoreductase-derived reactive species: Physiological and Pathological Effects. Oxid. Med. Cell. Longev. 2016, 2016, 3527579.
123. Harrison, R. Milk xanthine oxidase: Properties and physiological roles. Int. Dairy J. 2006, 16, 546-554.
124. Stevens, C.R.; Millar, T.M.; Clinch, J.G.; Kanczler, J.M.; Bodamyali, T.; Blake, D.R. Antibacterial properties of xanthine oxidase in human milk. Lancet 2000, 356, 829-830.
125. Yolken, R.H.; Peterson, J.A.; Vonderfecht, S.L.; Fouts, E.T.; Midthun, K.; Newburg, D.S. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Investig. 1992, 90, 1984-1991.
126. Newburg, D.S.; Peterson, J.A.; Ruiz-Palacios, G.M.; Matson, D.O.; Morrow, A.L.; Shults, J.; Guerrero, M.L.; Chaturvedi, P.; Newburg, S.O.; Scallan, C.D. et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998, 351, 1160-1164.
127. Smilowitz, J.T.; Lebrilla, C.B.; Mills, D.A.; German, J.B.; Freeman, S.L. Breast milk oligosaccharides: Structure-function relationships in the neonate. Annu. Rev. Nutr. 2014, 34, 143-169.
128. Bu, H.F.; Zuo, X.L.; Wang, X.; Ensslin, M.A.; Koti, V.; Hsueh, W.; Raymond, A.S.; Shur, B.D.; Tan, X.D. Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J. Clin. Investig.2007, 117, 3673-3683.
129. Hanayama, R.; Tanaka, M.; Miwa, K.; Shinohara, A.; Iwamatsu, A.; Nagata, S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002, 417, 182-187.
130. Raymond, A.; Ensslin, M.A.; Shur, B.D. SED1/MFG-E8: A bi-motif protein that orchestrates diverse cellular interactions. J. Cell. Biochem. 2009, 106, 957-966.
131. Rhodes, D.A.; Reith, W.; Trowsdale, J. Regulation of immunity by butyrophilins. Annu. Rev. Immunol. 2016, 34, 151-172.
132. Ogg, S.L.; Weldon, A.K.; Dobbie, L.; Smith, A.J.; Mather, I.H. Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc. Natl. Acad. Sci. USA 2004, 101, 10084-10089.
133. Smith, I.A.; Knezevic, B.R.; Ammann, J.U.; Rhodes, D.A.; Aw, D.; Palmer, D.B.; Mather, I.H.; Trowsdale, J. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 2010, 184, 3514-3525.
134. Lu, J.; Wang, X.; Zhang, W.; Liu, L.; Pang, X.; Zhang, S.; Lv, J. Comparative proteomics of milk fat globule membrane in different species reveals variations in lactation and nutrition. Food Chem. 2016, 196, 665-672.
135. Kuchta, A.M.; Kelly, P.M.; Stanton, C.; Devery, R.A. Milk fat globule membrane-a source of polar lipids for colon health? A review. Int. J. Dairy Technol. 2012, 65, 315-333.
136. Nilsson, A. Role of sphingolipids in infant gut health and immunity. J. Pediatr. 2016, 173, S53-S59.
137. Motouri, M.; Matsuyama, H.; Yamamura, J.; Tanaka, M.; Aoe, S.; Iwanaga, T.; Kawakami, H. Milk sphingomyelin accelerates enzymatic and morphological maturation of the intestine in artificially reared rats. J. Pediatr. Gastroenterol. Nutr. 2003, 36, 241-247.
138. Duan, R.D.; Nilsson, A. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog. Lipid Res. 2009, 48, 62-72.
139. Kunisawa, J.; Kiyono, H. Immunological function of sphingosine 1-phosphate in the intestine. Nutrients 2012, 4, 154-166.
140. Haruta-Ono, Y.; Setoguchi, S.; Ueno, H.M.; Higurashi, S.; Ueda, N.; Kato, K.; Saito, T.; Matsunaga, K.; Takata, J. Orally administered sphingomyelin in bovine milk is incorporated into skin sphingolipids and is involved in the water-holding capacity of hairless mice. J. Dermatol. Sci. 2012, 68, 56-62.
141. Oshida, K.; Shimizu, T.; Takase, M.; Tamura, Y.; Shimizu, T.; Yamashiro, Y. Effects of dietary sphingomyelin on central nervous system myelination in developing rats. Pediatr. Res. 2003, 53, 589-593.
142. Palmano, K.; Rowan, A.; Guillermo, R.; Guan, J.; McJarrow, P. The role of gangliosides in neurodevelopment. Nutrients 2015, 7, 3891-3913.
143. Rueda, R. The role of dietary gangliosides on immunity and the prevention of infection. Br. J. Nutr. 2007, 98, S68-S73.
144. Berding, K.; Wang, M.; Monaco, M.H.; Alexander, L.S.; Mudd, A.T.; Chichlowski, M.; Waworuntu, R.V.; Berg, B.M.; Miller, M.J.; Dilger, R.N. et al. Prebiotics and bioactive milk fractions affect gut development, microbiota, and neurotransmitter expression in piglets. J. Pediatr. Gastroenterol. Nutr. 2016, 63, 688-697.
145. Bhinder, G.; Allaire, J.M.; Garcia, C.; Lau, J.T.; Chan, J.M.; Ryz, N.R.; Bosman, E.S.; Graef, F.A.; Crowley, S.M.; Celiberto, L.S. et al. Milk fat globule membrane supplementation in formula modulates the neonatal gut microbiome and normalizes intestinal development. Sci. Rep. 2017, 7, 45274.
146. Claumarchirant, L.; Cilla, A.; Matencio, E.; Sanchez-Siles, L.M.; Castro-Gomez, P.; Fontecha, J.; Alegría, A.; Lagarda, M.J. Addition of milk fat globule membrane as an ingredient of infant formulas for resembling the polar lipids of human milk. Int. Dairy J. 2016, 61, 228-238.
147. O’Riordan, N.; Kane, M.; Joshi, L.; Hickey, R.M. Structural and functional characteristics of bovine milk protein glycosylation. Glycobiology 2014, 24, 220-236.
148. Wang, B. Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition. Adv. Nutr. 2012, 3, 465S-472S.
149. Carlson, S.E. Early determinants of development: A lipid perspective. Am. J. Clin. Nutr. 2009, 89, 1523S-1529S.
150. Leermakers, E.T.; Moreira, E.M.; Kiefte-de Jong, J.C.; Darweesh, S.K.; Visser, T.; Voortman, T.; Bautista, P.K.; Chowdhury, R.; Gorman, D.; Bramer, W.M. et al. Effects of choline on health across the life course: A systematic review. Nutr. Rev. 2015, 73, 500-522.
151. Zavaleta, N.; Kvistgaard, A.S.; Graverholt, G.; Respicio, G.; Guija, H.; Valencia, N.; Lönnerdal, B. Efficacy of an MFGM-enriched complementary food in diarrhea, anemia, and micronutrient status in infants. J. Pediatr. Gastroenterol. Nutr.2011, 53, 561-568.
152. Veereman-Wauters, G.; Staelens, S.; Rombaut, R.; Dewettinck, K.; Deboutte, D.; Brummer, R.J.; Boone, M.; Le Ruyet, P. Milk fat globule membrane (INPULSE) enriched formula milk decreases febrile episodes and may improve behavioral regulation in young children. Nutrition 2012, 28, 749-752.
153. Poppitt, S.D.; McGregor, R.A.; Wiessing, K.R.; Goyal, V.K.; Chitkara, A.J.; Gupta, S.; Palmano, K.; Kuhn-Sherlock, B.; McConnell, M.A. Bovine complex milk lipid containing gangliosides for prevention of rotavirus infection and diarrhoea in northern Indian infants. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 167-171.
154. Billeaud, C.; Puccio, G.; Saliba, E.; Guillois, B.; Vaysse, C.; Pecquet, S.; Steenhout, P. Safety and tolerance evaluation of milk fat globule membrane-enriched infant formulas: A randomized controlled multicenter non-inferiority trial in healthy term infants. Clin. Med. Insights Pediatr. 2014, 8, 51-60.
155. Timby, N.; Domellöf, M.; Lönnerdal, B.; Hernell, O. Comment on “Safety and tolerance evaluation of milk fat globule membrane-enriched infant formulas: A randomized controlled multicenter non-inferiority trial in healthy term infants”. Clin. Med. Insights Pediatr. 2015, 9, 63-64.
156. Timby, N.; Domellöf, E.; Hernell, O.; Lönnerdal, B.; Domellöf, M. Neurodevelopment, nutrition, and growth until 12 months of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: A randomized controlled trial. Am. J. Clin. Nutr. 2014, 99, 860-868.
157. Timby, N.; Lönnerdal, B.; Hernell, O.; Domellöf, M. Cardiovascular risk markers until 12 mo of age in infants fed a formula supplemented with bovine milk fat globule membranes. Pediatr. Res. 2014, 76, 394-400.
158. Timby, N.; Hernell, O.; Vaarala, O.; Melin, M.; Lönnerdal, B.; Domellöf, M. Infections in infants fed formula supplemented with bovine milk fat globule membranes. J. Pediatr. Gastroenterol. Nutr. 2015, 60, 384-389.
159. Gurnida, D.A.; Rowan, A.M.; Idjradinata, P.; Muchtadi, D.; Sekarwana, N. Association of complex lipids containing gangliosides with cognitive development of 6-month-old infants. Early Hum. Dev. 2012, 88, 595-601.